Facial Implant Panel Endorsement Masks Study Bias Concerns
This article was originally published in The Gray Sheet
Executive Summary
Potential biases resulting from the use of patients as their own controls within Q-Med's Restylane pivotal trial drew criticism during FDA panel review of the hyaluronic acid-based dermal filler Nov. 21